compounded semaglutide doses (GLP-1) Compounded Semaglutide Dosing Guide: Safe

Mounjaro, known generically as Tirzepatide, is not only a GLP-1 receptor agonist but also incorporates the effects of GIP (Glucose-dependent Insulinotropic Polypeptide)

It causes notable side effects including insomnia, night sweats, and cardiovascular strain

For now, the best path forward is to stick with therapies backed by solid, long-term data, using GLP-1 agonists as a potential supplement for managing metabolic issues

Meanwhile, dual agonists, which target and activate both the GLP-1 (Glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, and triple agonists (targeting the GLP-1+GIP+Glucagon receptors) are also showing promise

Carbohydrates dont need to be eliminated